Recent Publications

Switch to: List view

The following papers have been supported by the CEED3 project:

Lead Authorsort icon Other Authors Publication Title Date Published Journal Volume Pages
Abdul-Ghani MA Abdul-Ghani T, Müller G, Bergmann A, Fischer S, Bornstein S, Defronzo RA, Schwarz P Role of Glycated Hemoglobin in the Prediction of Future Risk of T2DM June 2011 Journal of Clinical Endocrinology & Metabolism Aug 2011;96(8) 2596-600
Ahlqvist E Turrini F, Lang ST, Taneera J, Zhou Y, Almgren P, Hansson O, Isomaa B, Tuomi T, Eriksson K, Eriksson JG, Lyssenko V, Groop L. A common variant upstream of the PAX6 gene influences islet function in man September 2011 Diabetologia Jan 2012;55(1) 94-104
Alkayyali S Lajer M, Deshmukh H, Ahlqvist E, Colhoun H, Isomaa B, Rossing P, Groop L, Lyssenko V. Common variant in the HMGA2 gene increases susceptibility to nephropathy in patients with type 2 diabetes October 2012 DIABETOLOGIA 56(2) 323-9
Almgren P Lehtovirta M, Isomaa B, Sarelin L, Taskinen MR, Lyssenko V, Tuomi T, Groop L; Botnia Study Group Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia Study August 2011 Diabetologia Nov 2011; 54(11) 2811-9
Besser RE Shepherd MH, McDonald TJ, Shields BM, Knight BA, Ellard S, Hattersley AT. Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes. February 2011 Diabetes Care 34(2) 286-91
Besser RE Shepherd MH, McDonald TJ, Shields BM, Knight BA, Ellard S, Hattersley AT Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes February 2011 Diabetes Care Feb 2011;34:(2) 86-91
Besser RE, Jones J, McDonald TJ, Smith R, Shepherd MH, Hattersley AT. Using highly sensitive C-reactive protein measurement to diagnose MODY in a family with suspected type 2 diabetes. July 2012 British Medical Journal Jul 11;2012
Boj SF Petrov D, Ferrer J Epistasis of transcriptomes reveals synergism between transcriptional activators Hnf1alpha and Hnf4alpha May 2010 PLoS Genet 6(5) e1000970
Boj SF Servitja JM, Martin D, Rios M, Talianidis I, Guigo R, Ferrer J Functional targets of the monogenic diabetes transcription factors HNF-1apha and HNF-4alpha are high conserved between mice and humans May 2009 Diabetes 58(5) 1245-53
Boj SF Petrov D, Ferrer J. Epistasis of transcriptomes reveals synergism between transcriptional activators Hnf1alpha and Hnf4a May 2010 PLoS Genet May 2010 27;6(5) el1000970
Boj SF Servitja JM, Martin D, Rios M, Talianidis I, Guigo R, Ferrer J. Functional targets of the monogenic diabetes transcription factors HNF-1alpha and HNF-4alpha are highly conserved between mice and humans. February 2009 Diabetes May 2009;58(5) 1245-53
Borowiec M Fendler W, Dusatkova P, Antosik K, Pruhova S, Cinek O, Mysliwiec M, Jarosz-Chobot P, Malecki MT, Mlynarski W HbA1c-based diabetes diagnosis among patients with glucokinase mutation (GCK-MODY) is affected by a genetic variant of glucose-6-phosphatase (G6PC2) October 2012 Diabetic Medicine Nov 2012;29 (11) 1465-9
Bowman P Flanagan SE, Edghill EL, Damhuis A, Shepherd MH, Paisey R, Hattersley AT, Ellard S. Heterozygous ABCC8 mutations are a cause of MODY October 2011 Diabetologia Jan 2012 55(1) 123–127
Calvet JH Dupin J, Winiecki H, Schwarz PE. Assessment of Small Fiber Neuropathy through a Quick, Simple and Non Invasive Method in a German Diabetes Outpatient Clinic October 2012 EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
Cervin C Axler O, Holmkvist J, Almgren P, Rantala E, Tuomi T, Groop L, Dahlbäck B, Karlsson E An investigation of serum concentration of apoM as a potential MODY3 marker using a novel ELISA March 2010 J Intern Med 267(3) 316-21